Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cystic Fibrosis | 21 | 2024 | 1284 | 4.030 |
Why?
|
Systemic Inflammatory Response Syndrome | 14 | 2024 | 621 | 2.840 |
Why?
|
Myocarditis | 3 | 2023 | 803 | 1.420 |
Why?
|
Lung Diseases | 4 | 2020 | 1939 | 1.210 |
Why?
|
Pseudomonas aeruginosa | 9 | 2024 | 1276 | 1.190 |
Why?
|
Neutrophils | 9 | 2022 | 3769 | 1.180 |
Why?
|
Respiratory Mucosa | 3 | 2024 | 437 | 1.080 |
Why?
|
Transendothelial and Transepithelial Migration | 4 | 2017 | 100 | 0.930 |
Why?
|
Antibodies, Viral | 13 | 2024 | 3213 | 0.910 |
Why?
|
Pseudomonas Infections | 4 | 2024 | 622 | 0.790 |
Why?
|
Connective Tissue Diseases | 2 | 2023 | 284 | 0.780 |
Why?
|
Lung Transplantation | 2 | 2020 | 1311 | 0.710 |
Why?
|
Haptoglobins | 1 | 2021 | 165 | 0.680 |
Why?
|
Endocannabinoids | 1 | 2021 | 114 | 0.680 |
Why?
|
Child | 35 | 2024 | 80568 | 0.650 |
Why?
|
Eicosanoids | 1 | 2021 | 284 | 0.630 |
Why?
|
Specimen Handling | 2 | 2020 | 704 | 0.630 |
Why?
|
Glycogen Storage Disease | 1 | 2018 | 41 | 0.620 |
Why?
|
Coculture Techniques | 4 | 2022 | 1336 | 0.600 |
Why?
|
Antigens, Human Platelet | 1 | 2017 | 41 | 0.570 |
Why?
|
Referral and Consultation | 2 | 2020 | 3615 | 0.560 |
Why?
|
Protein Precursors | 1 | 2021 | 1133 | 0.550 |
Why?
|
Monocytes | 5 | 2025 | 2591 | 0.540 |
Why?
|
Advance Directives | 1 | 2018 | 249 | 0.540 |
Why?
|
Viral Load | 3 | 2021 | 3385 | 0.510 |
Why?
|
Pregnancy Complications, Infectious | 6 | 2024 | 2184 | 0.500 |
Why?
|
Adaptive Immunity | 3 | 2021 | 733 | 0.490 |
Why?
|
Benzodioxoles | 3 | 2024 | 80 | 0.480 |
Why?
|
Aminophenols | 3 | 2024 | 93 | 0.480 |
Why?
|
Patient Preference | 2 | 2020 | 947 | 0.460 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3109 | 0.450 |
Why?
|
DNA Transposable Elements | 1 | 2018 | 765 | 0.450 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3231 | 0.450 |
Why?
|
Mutagenesis | 1 | 2018 | 1226 | 0.450 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 4 | 2024 | 452 | 0.440 |
Why?
|
Palliative Care | 4 | 2024 | 3640 | 0.420 |
Why?
|
8,11,14-Eicosatrienoic Acid | 3 | 2017 | 64 | 0.410 |
Why?
|
Humans | 84 | 2025 | 765926 | 0.400 |
Why?
|
Bronchoscopes | 1 | 2012 | 64 | 0.390 |
Why?
|
Immunoglobulin A | 3 | 2024 | 992 | 0.380 |
Why?
|
Leukotriene B4 | 3 | 2017 | 281 | 0.370 |
Why?
|
Infant | 13 | 2024 | 36426 | 0.370 |
Why?
|
Child, Preschool | 13 | 2024 | 42510 | 0.370 |
Why?
|
Advance Care Planning | 1 | 2018 | 698 | 0.360 |
Why?
|
Pulmonary Aspergillosis | 1 | 2011 | 48 | 0.360 |
Why?
|
Respiratory Insufficiency | 1 | 2019 | 1241 | 0.360 |
Why?
|
Bronchoscopy | 2 | 2018 | 913 | 0.360 |
Why?
|
Respiratory System Abnormalities | 1 | 2011 | 67 | 0.350 |
Why?
|
Quinolones | 2 | 2024 | 387 | 0.350 |
Why?
|
Fiber Optic Technology | 1 | 2012 | 290 | 0.340 |
Why?
|
Pandemics | 9 | 2023 | 8721 | 0.340 |
Why?
|
Intestinal Mucosa | 1 | 2021 | 3048 | 0.340 |
Why?
|
Cell Culture Techniques | 1 | 2017 | 1650 | 0.340 |
Why?
|
Immunoglobulin G | 6 | 2024 | 4555 | 0.330 |
Why?
|
Lung Diseases, Interstitial | 1 | 2018 | 940 | 0.330 |
Why?
|
Immunity, Humoral | 2 | 2024 | 607 | 0.320 |
Why?
|
Lung | 5 | 2022 | 10046 | 0.310 |
Why?
|
Hypertension, Pulmonary | 1 | 2020 | 1604 | 0.310 |
Why?
|
Mesenchymal Stem Cells | 1 | 2019 | 1663 | 0.310 |
Why?
|
Airway Management | 1 | 2012 | 325 | 0.310 |
Why?
|
Infant, Newborn | 12 | 2022 | 26380 | 0.300 |
Why?
|
Antibody Formation | 2 | 2022 | 1392 | 0.290 |
Why?
|
Inflammation | 8 | 2022 | 10843 | 0.290 |
Why?
|
Quality of Life | 4 | 2024 | 13463 | 0.290 |
Why?
|
Young Adult | 13 | 2024 | 59857 | 0.280 |
Why?
|
Respiratory Tract Infections | 1 | 2015 | 1008 | 0.280 |
Why?
|
Physician-Patient Relations | 1 | 2020 | 3270 | 0.280 |
Why?
|
Adolescent | 17 | 2024 | 88811 | 0.280 |
Why?
|
Genetic Testing | 1 | 2020 | 3594 | 0.280 |
Why?
|
Vaccination | 6 | 2024 | 3430 | 0.270 |
Why?
|
Terminal Care | 1 | 2018 | 1769 | 0.270 |
Why?
|
Staphylococcus aureus | 3 | 2024 | 1422 | 0.270 |
Why?
|
Neutrophil Infiltration | 3 | 2017 | 393 | 0.260 |
Why?
|
Indoles | 2 | 2024 | 1833 | 0.250 |
Why?
|
Tomography, Optical Coherence | 4 | 2021 | 2876 | 0.250 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2020 | 4055 | 0.240 |
Why?
|
Placenta | 4 | 2022 | 1726 | 0.240 |
Why?
|
Phenazines | 1 | 2024 | 53 | 0.230 |
Why?
|
Cytokines | 3 | 2024 | 7417 | 0.230 |
Why?
|
Hyperglycemia | 2 | 2024 | 1389 | 0.230 |
Why?
|
Massachusetts | 3 | 2022 | 8882 | 0.220 |
Why?
|
Epithelium | 2 | 2019 | 1603 | 0.220 |
Why?
|
Epithelial Cells | 3 | 2022 | 3684 | 0.220 |
Why?
|
Burns | 2 | 2025 | 1904 | 0.210 |
Why?
|
Cell Movement | 3 | 2021 | 5190 | 0.210 |
Why?
|
Opiate Alkaloids | 1 | 2023 | 27 | 0.210 |
Why?
|
Immunity | 4 | 2022 | 1000 | 0.210 |
Why?
|
Health Promotion | 1 | 2015 | 2208 | 0.200 |
Why?
|
Microbial Sensitivity Tests | 3 | 2024 | 1970 | 0.200 |
Why?
|
Primary Health Care | 1 | 2019 | 4736 | 0.200 |
Why?
|
Nasopharynx | 1 | 2024 | 419 | 0.190 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5752 | 0.190 |
Why?
|
Drug Combinations | 2 | 2024 | 2075 | 0.190 |
Why?
|
Adult | 25 | 2025 | 223088 | 0.180 |
Why?
|
Immunity, Mucosal | 1 | 2024 | 498 | 0.180 |
Why?
|
Anti-Bacterial Agents | 5 | 2024 | 7473 | 0.180 |
Why?
|
Complementarity Determining Regions | 1 | 2021 | 154 | 0.180 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2020 | 112 | 0.170 |
Why?
|
Chemotaxis, Leukocyte | 3 | 2017 | 656 | 0.170 |
Why?
|
Saliva | 1 | 2024 | 852 | 0.170 |
Why?
|
Female | 34 | 2025 | 396141 | 0.170 |
Why?
|
DNA | 1 | 2013 | 7193 | 0.170 |
Why?
|
Pepsin A | 1 | 2019 | 64 | 0.170 |
Why?
|
Bile | 1 | 2020 | 300 | 0.160 |
Why?
|
Lymphopenia | 1 | 2022 | 298 | 0.160 |
Why?
|
Gastric Acid | 1 | 2019 | 98 | 0.160 |
Why?
|
Permeability | 1 | 2021 | 726 | 0.160 |
Why?
|
Nuclear Proteins | 1 | 2013 | 5782 | 0.160 |
Why?
|
Forced Expiratory Volume | 2 | 2023 | 1828 | 0.150 |
Why?
|
Maternal-Fetal Exchange | 1 | 2020 | 453 | 0.150 |
Why?
|
Aspergillus fumigatus | 1 | 2020 | 158 | 0.150 |
Why?
|
Male | 24 | 2025 | 363815 | 0.150 |
Why?
|
Docosahexaenoic Acids | 1 | 2025 | 916 | 0.150 |
Why?
|
Aspergillosis | 1 | 2020 | 242 | 0.150 |
Why?
|
Candida albicans | 1 | 2021 | 377 | 0.150 |
Why?
|
Tobramycin | 1 | 2017 | 65 | 0.140 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2021 | 812 | 0.140 |
Why?
|
Antigens, Viral | 1 | 2021 | 995 | 0.140 |
Why?
|
Pyrazoles | 2 | 2024 | 2031 | 0.140 |
Why?
|
Fumarates | 1 | 2017 | 132 | 0.140 |
Why?
|
Infectious Disease Transmission, Vertical | 2 | 2021 | 1353 | 0.140 |
Why?
|
Bacteria | 2 | 2020 | 2210 | 0.140 |
Why?
|
Cell Wall | 1 | 2020 | 419 | 0.140 |
Why?
|
New England | 1 | 2020 | 1059 | 0.140 |
Why?
|
Pediatrics | 3 | 2020 | 3609 | 0.130 |
Why?
|
Cell Line | 4 | 2019 | 15540 | 0.130 |
Why?
|
RNA, Messenger | 4 | 2024 | 12768 | 0.130 |
Why?
|
Virus Internalization | 1 | 2020 | 502 | 0.130 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 18074 | 0.130 |
Why?
|
Oligopeptides | 1 | 2021 | 1193 | 0.130 |
Why?
|
Age Factors | 2 | 2024 | 18382 | 0.130 |
Why?
|
Drug Resistance, Bacterial | 2 | 2020 | 1065 | 0.130 |
Why?
|
Pulmonary Alveoli | 1 | 2018 | 665 | 0.120 |
Why?
|
Nose | 1 | 2019 | 518 | 0.120 |
Why?
|
Mutagenesis, Insertional | 1 | 2018 | 662 | 0.120 |
Why?
|
Phagocytosis | 1 | 2021 | 1517 | 0.120 |
Why?
|
Fetal Development | 1 | 2020 | 777 | 0.120 |
Why?
|
Staphylococcal Infections | 1 | 2024 | 1392 | 0.120 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2021 | 789 | 0.120 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2021 | 1362 | 0.120 |
Why?
|
Chemotaxis | 1 | 2017 | 596 | 0.110 |
Why?
|
Cytosol | 1 | 2017 | 885 | 0.110 |
Why?
|
Neoplasms | 1 | 2023 | 22340 | 0.110 |
Why?
|
Cell Polarity | 1 | 2017 | 636 | 0.110 |
Why?
|
Ambulatory Care Facilities | 1 | 2020 | 937 | 0.110 |
Why?
|
Autoantibodies | 1 | 2023 | 2114 | 0.110 |
Why?
|
Fetal Blood | 1 | 2020 | 1365 | 0.110 |
Why?
|
Peroxidase | 1 | 2017 | 609 | 0.110 |
Why?
|
Transcription Factors | 1 | 2013 | 12129 | 0.110 |
Why?
|
Autoimmunity | 1 | 2021 | 1354 | 0.110 |
Why?
|
Fluorescent Antibody Technique | 1 | 2017 | 2470 | 0.100 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 26282 | 0.100 |
Why?
|
Bacterial Proteins | 3 | 2024 | 3829 | 0.100 |
Why?
|
Acute Disease | 1 | 2023 | 7236 | 0.100 |
Why?
|
Rhinitis | 1 | 2020 | 752 | 0.100 |
Why?
|
Nanoparticles | 1 | 2024 | 1966 | 0.100 |
Why?
|
Biofilms | 3 | 2024 | 641 | 0.100 |
Why?
|
Cost of Illness | 2 | 2023 | 1949 | 0.100 |
Why?
|
Immunity, Innate | 2 | 2022 | 3078 | 0.100 |
Why?
|
Pregnancy | 9 | 2024 | 30230 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2021 | 1802 | 0.090 |
Why?
|
Patient Participation | 1 | 2020 | 1447 | 0.090 |
Why?
|
Case-Control Studies | 4 | 2021 | 22228 | 0.090 |
Why?
|
Adaptation, Psychological | 2 | 2019 | 2662 | 0.090 |
Why?
|
Sinusitis | 1 | 2020 | 995 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2024 | 4641 | 0.090 |
Why?
|
Severity of Illness Index | 4 | 2021 | 15878 | 0.090 |
Why?
|
Mutation | 2 | 2023 | 30192 | 0.090 |
Why?
|
Cell Communication | 1 | 2017 | 1660 | 0.090 |
Why?
|
Dendritic Cells | 1 | 2021 | 2745 | 0.090 |
Why?
|
Consensus | 1 | 2020 | 3202 | 0.090 |
Why?
|
Lactation | 2 | 2022 | 391 | 0.080 |
Why?
|
Blood Glucose Self-Monitoring | 2 | 2024 | 475 | 0.080 |
Why?
|
Quinolines | 2 | 2024 | 769 | 0.080 |
Why?
|
Depression | 2 | 2019 | 8223 | 0.070 |
Why?
|
Influenza A virus | 2 | 2022 | 453 | 0.070 |
Why?
|
T-Lymphocytes | 2 | 2023 | 10256 | 0.070 |
Why?
|
Membrane Transport Proteins | 2 | 2024 | 1028 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3247 | 0.070 |
Why?
|
Biopsy | 1 | 2018 | 6766 | 0.070 |
Why?
|
Substance-Related Disorders | 1 | 2023 | 4418 | 0.070 |
Why?
|
Imaging, Three-Dimensional | 1 | 2019 | 4037 | 0.060 |
Why?
|
Comorbidity | 1 | 2020 | 10575 | 0.060 |
Why?
|
Pilot Projects | 1 | 2019 | 8724 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2024 | 5889 | 0.060 |
Why?
|
Virulence | 2 | 2020 | 1289 | 0.060 |
Why?
|
Sexual Behavior | 1 | 2015 | 2192 | 0.060 |
Why?
|
Animals | 5 | 2021 | 168735 | 0.060 |
Why?
|
Mental Health | 1 | 2019 | 3272 | 0.060 |
Why?
|
Pyocyanine | 1 | 2024 | 20 | 0.060 |
Why?
|
Asthma | 1 | 2023 | 6268 | 0.060 |
Why?
|
Equipment Design | 1 | 2012 | 3490 | 0.060 |
Why?
|
Tetracycline | 1 | 2024 | 216 | 0.060 |
Why?
|
Carboxylic Acids | 1 | 2024 | 91 | 0.050 |
Why?
|
RNA, Viral | 2 | 2023 | 2866 | 0.050 |
Why?
|
Multidrug Resistance-Associated Proteins | 1 | 2024 | 105 | 0.050 |
Why?
|
Health Behavior | 1 | 2015 | 2649 | 0.050 |
Why?
|
Sulfates | 1 | 2024 | 375 | 0.050 |
Why?
|
Conscious Sedation | 1 | 2007 | 533 | 0.050 |
Why?
|
Alginates | 1 | 2024 | 247 | 0.050 |
Why?
|
United States | 4 | 2023 | 72909 | 0.050 |
Why?
|
Retinopathy of Prematurity | 1 | 2007 | 449 | 0.050 |
Why?
|
Antibodies, Neutralizing | 2 | 2023 | 2010 | 0.050 |
Why?
|
Pyridines | 2 | 2024 | 2885 | 0.050 |
Why?
|
Vaccines, Synthetic | 1 | 2024 | 622 | 0.050 |
Why?
|
Middle Aged | 6 | 2025 | 223016 | 0.050 |
Why?
|
Cohort Studies | 5 | 2023 | 41680 | 0.050 |
Why?
|
Anxiety | 1 | 2017 | 4669 | 0.050 |
Why?
|
Fomites | 1 | 2021 | 15 | 0.050 |
Why?
|
Aging | 1 | 2020 | 8725 | 0.050 |
Why?
|
Polysaccharides, Bacterial | 1 | 2024 | 576 | 0.050 |
Why?
|
Neutrophil Activation | 1 | 2021 | 180 | 0.040 |
Why?
|
Nasal Lavage | 1 | 2020 | 17 | 0.040 |
Why?
|
Hospitalization | 1 | 2020 | 10810 | 0.040 |
Why?
|
Communication | 1 | 2015 | 3908 | 0.040 |
Why?
|
Laser Therapy | 1 | 2007 | 1108 | 0.040 |
Why?
|
Naphthols | 1 | 2020 | 46 | 0.040 |
Why?
|
Asymptomatic Infections | 1 | 2021 | 136 | 0.040 |
Why?
|
Chlorides | 1 | 2023 | 666 | 0.040 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2024 | 592 | 0.040 |
Why?
|
Spores, Fungal | 1 | 2020 | 90 | 0.040 |
Why?
|
Spirometry | 1 | 2023 | 929 | 0.040 |
Why?
|
Mucociliary Clearance | 1 | 2019 | 81 | 0.040 |
Why?
|
Ebolavirus | 1 | 2022 | 250 | 0.040 |
Why?
|
Receptors, Fc | 1 | 2022 | 537 | 0.040 |
Why?
|
Interleukin-1beta | 1 | 2025 | 1027 | 0.040 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2021 | 545 | 0.040 |
Why?
|
Blood Glucose | 2 | 2024 | 6422 | 0.040 |
Why?
|
Aerosols | 1 | 2021 | 634 | 0.040 |
Why?
|
Esophageal pH Monitoring | 1 | 2019 | 203 | 0.040 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2024 | 1137 | 0.040 |
Why?
|
Pregnancy Trimester, Third | 1 | 2020 | 587 | 0.040 |
Why?
|
Perinatal Care | 1 | 2020 | 243 | 0.040 |
Why?
|
Pulmonary Medicine | 1 | 2020 | 223 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 12235 | 0.040 |
Why?
|
Melanins | 1 | 2020 | 291 | 0.040 |
Why?
|
Leukocytes, Mononuclear | 1 | 2024 | 1852 | 0.040 |
Why?
|
Needs Assessment | 1 | 2023 | 1140 | 0.040 |
Why?
|
Receptors, IgG | 1 | 2020 | 559 | 0.040 |
Why?
|
Granulocytes | 1 | 2019 | 548 | 0.040 |
Why?
|
Species Specificity | 1 | 2022 | 2406 | 0.040 |
Why?
|
Mucus | 1 | 2019 | 346 | 0.040 |
Why?
|
Risk Factors | 1 | 2024 | 74850 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2017 | 6958 | 0.030 |
Why?
|
Carrier State | 1 | 2021 | 529 | 0.030 |
Why?
|
Bile Acids and Salts | 1 | 2019 | 398 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2025 | 2213 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2022 | 838 | 0.030 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2021 | 538 | 0.030 |
Why?
|
Azithromycin | 1 | 2017 | 202 | 0.030 |
Why?
|
Disease Progression | 2 | 2023 | 13614 | 0.030 |
Why?
|
Mice | 3 | 2017 | 81782 | 0.030 |
Why?
|
Health Services Needs and Demand | 1 | 2023 | 1404 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 2020 | 1527 | 0.030 |
Why?
|
Aged | 4 | 2025 | 171163 | 0.030 |
Why?
|
Outpatients | 1 | 2023 | 1595 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 2020 | 1024 | 0.030 |
Why?
|
Cilia | 1 | 2019 | 499 | 0.030 |
Why?
|
Sputum | 1 | 2017 | 513 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2019 | 2476 | 0.030 |
Why?
|
Viral Proteins | 1 | 2022 | 1798 | 0.030 |
Why?
|
Receptors, Leukotriene B4 | 1 | 2014 | 93 | 0.030 |
Why?
|
Psychometrics | 1 | 2024 | 3061 | 0.030 |
Why?
|
Intestine, Small | 1 | 2020 | 1216 | 0.030 |
Why?
|
Proton Pump Inhibitors | 1 | 2019 | 551 | 0.030 |
Why?
|
Prospective Studies | 3 | 2024 | 54807 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 1 | 2022 | 1812 | 0.030 |
Why?
|
Patient Care Management | 1 | 2017 | 301 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3343 | 0.030 |
Why?
|
Infection Control | 1 | 2021 | 984 | 0.030 |
Why?
|
Models, Organizational | 1 | 2017 | 548 | 0.030 |
Why?
|
Esophagus | 1 | 2019 | 1038 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2018 | 59496 | 0.030 |
Why?
|
Otolaryngology | 1 | 2020 | 698 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2024 | 4405 | 0.020 |
Why?
|
Gastroesophageal Reflux | 1 | 2019 | 834 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2020 | 2444 | 0.020 |
Why?
|
Length of Stay | 1 | 2025 | 6486 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2023 | 3053 | 0.020 |
Why?
|
Sepsis | 1 | 2025 | 2603 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2017 | 3089 | 0.020 |
Why?
|
Calcium Signaling | 1 | 2014 | 733 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 1601 | 0.020 |
Why?
|
Blotting, Western | 1 | 2017 | 5019 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2023 | 12417 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2022 | 4782 | 0.020 |
Why?
|
Patient Selection | 1 | 2020 | 4248 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 20690 | 0.020 |
Why?
|
Proteomics | 1 | 2021 | 3906 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2017 | 6306 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2023 | 14745 | 0.020 |
Why?
|
Bacterial Infections | 1 | 2014 | 1387 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2024 | 20133 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2022 | 9525 | 0.020 |
Why?
|
Chronic Disease | 1 | 2020 | 9351 | 0.020 |
Why?
|
Smoking | 1 | 2021 | 9082 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2020 | 17060 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 18962 | 0.010 |
Why?
|
Time Factors | 1 | 2022 | 40097 | 0.010 |
Why?
|
Intubation, Intratracheal | 1 | 2007 | 1359 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22327 | 0.010 |
Why?
|
Respiration, Artificial | 1 | 2007 | 2726 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18292 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2021 | 81537 | 0.010 |
Why?
|